Word: wyeth
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...deploy assets this year and beyond, save room for dividend payers. Byron Wien, market strategist at Morgan Stanley, predicts that a surge in the prices of stocks with a yield will be one of the big surprises of 2004 and that the year's winners will include Pfizer, Wyeth, Bristol-Myers, GE, Microsoft (it started paying a dividend last year), Coca-Cola and Altria. Any number of mutual funds focus on dividend payers. Among the best are Fidelity Dividend Growth, T. Rowe Price Dividend Growth and (if you invest through a broker) Capital Income Builder from the American Funds group...
...raised a postmenopausal woman's risk of heart disease and breast cancer but also increased her risk of stroke and doubled her chances of developing dementia if she was 65 or older. The grim research results, on top of those released in 2002, have translated into plummeting prescriptions for Wyeth Pharmaceuticals, manufacturer of Prempro (the company also helped fund the critical studies): the tally of 2003 sales of the hormone combo is expected to be down 50% from 2002 sales, which were down 25% from 2001 sales...
Although the study results directly apply only to Prempro, its conclusions probably also cover other estrogen-progestin combinations. At any rate, those drugs would need to be studied as vigorously as Prempro has been for any manufacturer to claim otherwise. (Wyeth Pharmaceuticals deserves a good corporate-citizenship award for allowing its product to be so thoroughly vetted and for even paying for some of the work.) It is also important to recognize that the absolute number of extra cases of Alzheimer's disease due to HRT is very small...
...arthritic pain, while sparing the COX-1 enzyme, which helps dogs (and people) protect their stomach linings. This relief method puts Deramaxx in the same class as Celebrex (Pfizer) and Vioxx (Merck), which are for humans. Vets expect Deramaxx to cut into sales of Pfizer's Rimadyl and Wyeth's EtoGesic, which dominate the $150 million U.S. dog-arthritis market. Deramaxx will cost about $30 a month. Novartis plans to release it soon worldwide...
...final site includes two Victorian structures—the Harvard Ukrainian Research Institute and Baker House, HLS’s legal aid office—and Wyeth Hall, a six-story red-brick dormitory...